That’s exactly what the clinical trials on the “𝗣𝗼𝗺𝗽𝘂𝗿” apple variety are all about, led by 𝗣𝗿𝗼𝗳. Dr. Karl-Christian Bergmann, Medical Director of the ECARF Institute, at the 21st German Allergy Congress in Wiesbaden.
Many people with a pollen allergy also react to apples. The reason: An apple allergen is similar to the birch pollen allergen and can trigger symptoms in the mouth and throat.
“Pompur” underwent clinical testing over a three-year period in a joint effort by ECARF, Charité, the Technical University of Munich, and Osnabrück University of Applied Sciences. The results remained consistent across all three years of testing: Participants were able to eat the apple without experiencing any symptoms during the trials.
“Pompur” has been available in stores since November 2025.
𝟭.–𝟯. 𝗢𝗸𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟲
RheinMain CongressCenter, Wiesbaden
More information on the certification:
https://www.ecarf-institute.org/produkte/apfelsorte-zin-168/
𝗞𝘂𝗿𝘇 𝗴𝗲𝘀𝗮𝗴𝘁:
Research can have a very tangible impact on everyday life—sometimes even in the form of an apple.